Pulse 탐색 nav.journalClub 토론 트렌드 연구자 저널

홈 탐색 nav.journalClub 트렌드

⌘+K

WCN26-7163 Disease activity assessed by glomerular Gd-IgA1 deposition | Synapse

March 28, 2026Kidney International Reports0 citationsOpen Access

WCN26-7163 Disease activity assessed by glomerular Gd-IgA1 deposition

MAMai AkimotoJuntendo University Urayasu Hospital KMKazuaki MoriJuntendo University RARyousuke Aoki

Key Points

To assess the effect of hydroxychloroquine on proteinuria levels in non-Chinese patients with glomerular Gd-IgA1 deposition.
Single center study design
Evaluation of hydroxychloroquine treatment
Assessment of proteinuria levels at 6 months
Focus on non-Chinese patient population
28% of patients experienced a reduction in proteinuria
Hydroxychloroquine was well tolerated
Further research needed for diverse populations

Abstract

Conclusion:In this single center study, HCQ was well tolerated and effective in lowering proteinuria at 6 months in 28% of non-Chinese patients.Further prospective research in diverse populations and evaluation of ethnicities that may benefit most from HCQ is warranted.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

AI에게 질문

Like

Bookmark

Share

View Full Paper

Cite This Study

Akimoto et al. (Wed,) studied this question.

synapsesocial.com/papers/69c770888bbfbc51511e0a24 https://doi.org/https://doi.org/10.1016/j.ekir.2026.106288

AI에게 질문

Like

Bookmark

Share

View Full Paper